New Evidence for Neoadjuvant Therapy in Advanced Melanoma

H&O What was the history behind the SWOG S1801 study that you presented at the most recent European Society for Medical Oncology congress? SP The benefits […]

Advances in Borderline Resectable Pancreatic Adenocarcinoma

Abstract: Pancreatic adenocarcinoma is one of the most lethal cancers in oncology. Pancreatic cancer is the third most common cause of cancer-related mortality in the United […]

Changing Local Therapy in Breast Cancer: Who Needs What, and When?

Abstract: The local therapy of breast cancer continues to evolve toward less surgery. Breast conservation is firmly in place, with recent trends toward decreased rates […]